Advances in the study and treatment of genetic cardiomyopathies

Victoria N Parikh1, Sharlene M Day2, Neal K Lakdawala3

  • 1Stanford Center for Inherited Cardiovascular Disease, Stanford School of Medicine, Stanford, CA, USA.

Cell
|February 21, 2025
PubMed

Insights

Cardiomyopathies, heart muscle disorders, are classified into hypertrophic (HCM), dilated (DCM), and arrhythmogenic (ACM) types. Genetic insights are driving precision diagnosis, management, and novel therapies, including gene treatments, for these conditions.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are primary heart muscle diseases with distinct phenotypes.
  • Key types include hypertrophic (HCM), dilated (DCM), and arrhythmogenic (ACM) cardiomyopathies.
  • These conditions are characterized by specific morphological and functional abnormalities.

Purpose of the Study:

  • To highlight the impact of genetic discoveries on understanding cardiomyopathies.
  • To discuss the development of precision diagnostics and mechanistically based treatments.
  • To explore emergent gene therapies for cardiomyopathy.

Main Methods:

  • Review of genetic discoveries in cardiomyopathy.
  • Analysis of new therapeutic strategies.
  • Integration of molecular insights with clinical features.

Main Results:

  • Genetic research is improving diagnostic precision.
  • Mechanistically informed therapies are being developed.
  • Gene therapies show promise for restoring cardiac function.

Conclusions:

  • Genetic discoveries are revolutionizing cardiomyopathy care.
  • New treatments offer hope for improved patient outcomes.
  • This marks a new era in cardiac biology and patient management.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761